Victory Capital Management
STOK icon

Victory Capital Management’s Stoke Therapeutics STOK Stock Holding History

Victory Capital Management’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1M Sell
33,890
-7,250
-18% -$238K ﹤0.01% 1799
2025
Q4 		$1.31M Buy
+41,140
New +$1.24M ﹤0.01% 1707
2023
Q1 		– Sell
-18,581
Closed -$172K – 2687
2022
Q4 		$172K Sell
18,581
-1,217
-6% -$12.7K ﹤0.01% 2289
2022
Q3 		$254K Sell
19,798
-1,233
-6% -$19.6K ﹤0.01% 2298
2022
Q2 		$278K Buy
21,031
+807
+4% +$12.3K ﹤0.01% 2261
2022
Q1 		$292K Sell
20,224
-45,947
-69% -$920K ﹤0.01% 2307
2021
Q4 		$1.59M Buy
66,171
+12,689
+24% +$303K ﹤0.01% 1642
2021
Q3 		$1.36M Sell
53,482
-4,956
-8% -$138K ﹤0.01% 1722
2021
Q2 		$1.97M Sell
58,438
-3,421
-6% -$121K ﹤0.01% 1638
2021
Q1 		$2.4M Sell
61,859
-15,069
-20% -$858K ﹤0.01% 1595
2020
Q4 		$4.76M Buy
76,928
+9,352
+14% +$429K 0.01% 1255
2020
Q3 		$2.26M Sell
67,576
-9,686
-13% -$277K ﹤0.01% 1406
2020
Q2 		$1.84M Sell
77,262
-327,864
-81% -$7.78M ﹤0.01% 1466
2020
Q1 		$9.28M Buy
405,126
+225,478
+126% +$5.57M 0.01% 1109
2019
Q4 		$5.09M Buy
179,648
+175,735
+4,491% +$4.42M 0.01% 1183
2019
Q3 		$84K Buy
3,913
+1,413
+57% +$39.4K ﹤0.01% 2491
2019
Q2 		$73K Buy
+2,500
New +$67.1K ﹤0.01% 1679

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Victory Capital Management's STOK Position: Q1 2026 in Review

Victory Capital Management reduced its Stoke Therapeutics (STOK) stake by 18% in Q1 2026, selling an estimated $238K and leaving 33,890 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1799.

Victory Capital Management first reported a position in STOK in Q2 2019 and has held it in 17 quarters since. The position peaked at $9.28M in Q1 2020. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Victory Capital Management held 33,890 shares of Stoke Therapeutics worth $1.1M as of Q1 2026.
  • Victory Capital Management sold 7,250 Stoke Therapeutics shares in Q1 2026, an estimated $238K.
  • Stoke Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #1799 holding.
  • Victory Capital Management first reported a position in Stoke Therapeutics in Q2 2019 and has held it in 17 quarters since.
  • Victory Capital Management's Stoke Therapeutics position peaked at $9.28M in Q1 2020.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.